Background Data regarding the prevalence of potential interactions between travel-related
medications (TRM) and chronic medications in use, or medical conditions of travelers to
developing countries are limited. Methods A retrospective cohort study of travelers to low
income countries. We extracted data on demographics, travel destinations, use of chronic
medications, drug allergies, and relevant medical conditions. The following TRM were
evaluated: mefloquine, primaquine, doxycycline, atovaquone/proguanil, fluoroquinolone …